Skip Navigation



ToxSci Advance Access published online on May 22, 2008
Toxicological Sciences, doi:10.1093/toxsci/kfn103
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
105/1/134    most recent
kfn103v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Desire, T.-K.
Right arrow Articles by Peter, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desire, T.-K.
Right arrow Articles by Peter, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Probing mechanisms of axonopathy. Part I: Protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene.

Tshala-Katumbay Desire*,{ddagger}, Monterroso Victor{dagger}, Kayton Robert{ddagger}, Lasarev Michael{ddagger}, Sabri Mohammad*,{ddagger} and Spencer Peter*,{ddagger}

* Department of Neurology {dagger} Department of Comparative Medicine, School of Medicine {ddagger} Center for Research on Occupational & Environmental Toxicology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239

Corresponding Author Desire Tshala-Katumbay, M.D., Ph.D. Center for Research on Occupational and Environmental Toxicology Oregon Health & Science University 3181 S.W. Jackson Park Road, mail code L606 Portland, Oregon 97239 USA Email: tshalad{at}ohsu.edu Telephone: +1 503 494-0999 Facsimile: +1 503 494-6831

Received April 4, 2008; revision received May 16, 2008; accepted May 16, 2008


  Abstract

Motor neuron axonopathy in diseases such as amyotrophic lateral sclerosis can be modeled and probed with neurotoxic chemicals that induce similar patterns of pathology, such as axonal spheroids that represent focal accumulation of anterogradely transported neurofilaments. The aromatic {gamma}-diketone-like 1,2-diacetylbenzene (1,2-DAB), but not its 1,3-DAB isomer, reacts with {epsilon}-amino- or sulfyhydryl groups of (neuro)proteins, forms adducts, and causes neurofilaments to accumulate at proximal sites of elongate motor axons. We exploit the protein-reactive properties of neurotoxic 1,2-DAB vs. the non-protein-reactive properties of non-neurotoxic 1,3-DAB to unveil proteomic changes associated with this type of pathology. We used two-dimensional differential in-gel electrophoresis (2D-DIGE), matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry (MALDI-TOF/MS-MS) to analyze the lumbosacral spinal cord proteome of adult Sprague-Dawley rats treated systemically with 20 mg/kg/day 1,2-DAB, equimolar dose of 1,3-DAB, or equivalent volume of vehicle (saline containing 2% acetone), 5 days a week, for 2 weeks. 1,2-DAB significantly altered the expression of protein disulfide isomerase, an enzyme involved in protein folding, and gelsolin, an actin-capping and -severing protein. Modifications of these two proteins have been incriminated in the pathogenesis of nerve fiber degeneration. Protein-reactive and neurotoxic 1,2-DAB appears to be excellent tool to dissect mechanisms of nerve fiber (axon) degeneration.

Key Words: Axonal swellings; {gamma}-diketones; gelsolin; protein disulfide isomerase; proteomics; solvent neuropathy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol SciHome page
D. Tshala-Katumbay, V. Monterroso, R. Kayton, M. Lasarev, M. Sabri, and P. Spencer
Probing Mechanisms of Axonopathy. Part II: Protein Targets of 2,5-Hexanedione, the Neurotoxic Metabolite of the Aliphatic Solvent n-Hexane
Toxicol. Sci., February 1, 2009; 107(2): 482 - 489.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.